PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AUROPHARMA.NS vs. ^NIFTY200
Performance
Risk-Adjusted Performance
Drawdowns
Volatility

Key characteristics


AUROPHARMA.NS^NIFTY200
YTD Return6.88%6.54%
1Y Return81.61%31.47%
3Y Return (Ann)5.66%17.81%
5Y Return (Ann)12.62%16.67%
10Y Return (Ann)14.99%13.52%
Sharpe Ratio2.993.04
Daily Std Dev29.62%10.39%
Max Drawdown-86.50%-64.04%
Current Drawdown-1.95%-1.26%

Correlation

-0.50.00.51.00.5

The correlation between AUROPHARMA.NS and ^NIFTY200 is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

AUROPHARMA.NS vs. ^NIFTY200 - Performance Comparison

The year-to-date returns for both stocks are quite close, with AUROPHARMA.NS having a 6.88% return and ^NIFTY200 slightly lower at 6.54%. Over the past 10 years, AUROPHARMA.NS has outperformed ^NIFTY200 with an annualized return of 14.99%, while ^NIFTY200 has yielded a comparatively lower 13.52% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%December2024FebruaryMarchAprilMay
1,755.32%
248.41%
AUROPHARMA.NS
^NIFTY200

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Aurobindo Pharma Limited

NIFTY 200

Risk-Adjusted Performance

AUROPHARMA.NS vs. ^NIFTY200 - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Aurobindo Pharma Limited (AUROPHARMA.NS) and NIFTY 200 (^NIFTY200). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AUROPHARMA.NS
Sharpe ratio
The chart of Sharpe ratio for AUROPHARMA.NS, currently valued at 2.95, compared to the broader market-2.00-1.000.001.002.003.004.002.95
Sortino ratio
The chart of Sortino ratio for AUROPHARMA.NS, currently valued at 3.89, compared to the broader market-4.00-2.000.002.004.006.003.89
Omega ratio
The chart of Omega ratio for AUROPHARMA.NS, currently valued at 1.48, compared to the broader market0.501.001.502.001.48
Calmar ratio
The chart of Calmar ratio for AUROPHARMA.NS, currently valued at 1.81, compared to the broader market0.002.004.006.001.81
Martin ratio
The chart of Martin ratio for AUROPHARMA.NS, currently valued at 16.89, compared to the broader market-10.000.0010.0020.0030.0016.89
^NIFTY200
Sharpe ratio
The chart of Sharpe ratio for ^NIFTY200, currently valued at 2.57, compared to the broader market-2.00-1.000.001.002.003.004.002.57
Sortino ratio
The chart of Sortino ratio for ^NIFTY200, currently valued at 3.36, compared to the broader market-4.00-2.000.002.004.006.003.36
Omega ratio
The chart of Omega ratio for ^NIFTY200, currently valued at 1.44, compared to the broader market0.501.001.502.001.44
Calmar ratio
The chart of Calmar ratio for ^NIFTY200, currently valued at 2.33, compared to the broader market0.002.004.006.002.33
Martin ratio
The chart of Martin ratio for ^NIFTY200, currently valued at 14.36, compared to the broader market-10.000.0010.0020.0030.0014.36

AUROPHARMA.NS vs. ^NIFTY200 - Sharpe Ratio Comparison

The current AUROPHARMA.NS Sharpe Ratio is 2.99, which roughly equals the ^NIFTY200 Sharpe Ratio of 3.04. The chart below compares the 12-month rolling Sharpe Ratio of AUROPHARMA.NS and ^NIFTY200.


Rolling 12-month Sharpe Ratio1.002.003.004.005.006.00December2024FebruaryMarchAprilMay
2.95
2.57
AUROPHARMA.NS
^NIFTY200

Drawdowns

AUROPHARMA.NS vs. ^NIFTY200 - Drawdown Comparison

The maximum AUROPHARMA.NS drawdown since its inception was -86.50%, which is greater than ^NIFTY200's maximum drawdown of -64.04%. Use the drawdown chart below to compare losses from any high point for AUROPHARMA.NS and ^NIFTY200. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%December2024FebruaryMarchAprilMay
-1.95%
-1.26%
AUROPHARMA.NS
^NIFTY200

Volatility

AUROPHARMA.NS vs. ^NIFTY200 - Volatility Comparison

Aurobindo Pharma Limited (AUROPHARMA.NS) has a higher volatility of 8.48% compared to NIFTY 200 (^NIFTY200) at 3.01%. This indicates that AUROPHARMA.NS's price experiences larger fluctuations and is considered to be riskier than ^NIFTY200 based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%December2024FebruaryMarchAprilMay
8.48%
3.01%
AUROPHARMA.NS
^NIFTY200